Aspiriant LLC’s U.S. Targeted Value Portfolio ETF Class Shares DFAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-188,313
Closed -$13.2M – 434
2026
Q2
$13.2M Hold
188,313
– – 0.33% 43
2026
Q1
$11.8M Sell
188,313
-2,927
-2% -$186K 0.34% 41
2025
Q4
$11.4M Sell
191,240
-701
-0.4% -$40.9K 0.33% 42
2025
Q3
$11.2M Sell
191,941
-1,927
-1% -$110K 0.34% 39
2025
Q2
$10.5M Buy
193,868
+3,727
+2% +$190K 0.33% 38
2025
Q1
$9.8M Buy
190,141
+17,080
+10% +$940K 0.34% 36
2024
Q4
$9.6M Buy
173,061
+1,313
+0.8% +$75.1K 0.35% 37
2024
Q3
$9.6M Sell
171,748
-841
-0.5% -$45.5K 0.36% 38
2024
Q2
$8.95M Sell
172,589
-106
-0.1% -$5.56K 0.36% 39
2024
Q1
$9.4M Sell
172,695
-6,106
-3% -$314K 0.39% 36
2023
Q4
$9.36M Sell
178,801
-2,058
-1% -$96.2K 0.42% 36
2023
Q3
$8.26M Sell
180,859
-2,085
-1% -$99K 0.42% 36
2023
Q2
$8.49M Sell
182,944
-989
-0.5% -$43.4K 0.43% 36
2023
Q1
$8.19M Buy
183,933
+10
+0% +$464 0.43% 37
2022
Q4
$8.08M Sell
183,923
-2,072
-1% -$91K 0.41% 35
2022
Q3
$7.25M Hold
185,995
– – 0.35% 36
2022
Q2
$7.48M Sell
185,995
-2,772
-1% -$122K 0.36% 37
2022
Q1
$8.8M Buy
188,767
+2,213
+1% +$103K 0.48% 30
2021
Q4
$8.87M Sell
186,554
-11,563
-6% -$543K 0.47% 27
2021
Q3
$8.8M Sell
198,117
-7,126
-3% -$316K 0.52% 26
2021
Q2
$9.19M Buy
+205,243
New +$9.22M 0.52% 26

Other funds holding DFAT

Aspiriant LLC's DFAT Position: Q3 2026 in Review

Aspiriant LLC sold out of U.S. Targeted Value Portfolio ETF Class Shares (DFAT) in Q3 2026, closing a stake of 188,313 shares — an estimated $13.2M sold.

Aspiriant LLC first reported a position in DFAT in Q2 2021 and held it in 21 quarters. The position peaked at $13.2M in Q2 2026. 146 funds tracked by Wall St. Rank hold DFAT as of Q3 2026.

  • Aspiriant LLC reported no remaining U.S. Targeted Value Portfolio ETF Class Shares position as of Q3 2026 after selling out during the quarter.
  • Aspiriant LLC sold 188,313 U.S. Targeted Value Portfolio ETF Class Shares shares in Q3 2026, an estimated $13.2M.
  • Aspiriant LLC first reported a position in U.S. Targeted Value Portfolio ETF Class Shares in Q2 2021 and held it in 21 quarters.
  • Aspiriant LLC's U.S. Targeted Value Portfolio ETF Class Shares position peaked at $13.2M in Q2 2026.
  • 146 funds tracked by Wall St. Rank held U.S. Targeted Value Portfolio ETF Class Shares as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.